CYFANTIR owner Contact Information online
from Vertex Pharmaceuticals Incorporated
CYFANTIR
US serial number:85155461
Application filling date:Oct. 18, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Dec. 01, 2014
Publication date:Aug. 30, 2011
Abandoned date:Dec. 01, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of cystic fibrosis, viral diseases, bacterial infections, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
International Class(es): 005- Primary Class
U.S Class(es):
Services:Pharmaceutical preparations for the treatment of cystic fibrosis
viral diseases
bacterial infections
cancer
autoimmune diseases
inflammatory diseases
neurological disorders and epilepsy
Current owner owner name:Vertex Pharmaceuticals Incorporated
Current owner owner address:50 Northern Avenue
Boston,
MASSACHUSETTS
UNITED STATES
02210
Current owner legal entity type:CORPORATION
Current owner state or country:MASSACHUSETTS
Attorney name:Steven A. Abreu
Attorney email:trademarks@sunsteinlaw.com
Attorney docket number:1618/296
Attorney email authorized:Yes
Correspondent name address:STEVEN A. ABREU
SUNSTEIN KANN MURPHY & TIMBERS LLP
125 SUMMER ST
BOSTON,
MASSACHUSETTS
UNITED STATES
02110
Correspondent phone:617-443-9292
Correspondent email:trademarks@sunsteinlaw.com
Correspondent fax:617-443-0004
Correspondent email authorized:Yes
Trademark staff tm attorney:YAO, GRETTA
Trademark staff law office assigned CYFANTIR:LAW OFFICE 118
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) Western Holdings, LLC (21) MONSTER ENERGY COMPANY (19) Scott Riddell (17)Popular publication dates
Aug. 30, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Nov. 16, 2010 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
